Bethesda, MD, United States of America

Kira S Makarova

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 12.3

ph-index = 3

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kira S. Makarova: Pioneering CRISPR Innovator and Patent Holder

Introduction:

Meet Kira S. Makarova, a brilliant innovator hailing from Bethesda, MD (US). With an impressive portfolio of four patents and expertise in CRISPR enzymes and systems, Makarova has made significant contributions to the field of nucleic acid targeting. Let's delve into the latest patents, career highlights, and notable collaborations of this remarkable inventor.

Latest Patents:

Makarova's most recent patents revolve around CRISPR enzymes and systems. These groundbreaking inventions offer novel systems, methods, and compositions for the precise targeting of nucleic acids. Specifically, Makarova's work focuses on the development of non-naturally occurring or engineered RNA-targeting CRISPR effector proteins, paired with essential components such as guide RNA. These advancements open doors to various applications, including gene editing and therapeutic interventions.

Career Highlights:

Throughout their career, Kira S. Makarova has worked at distinguished institutions such as The Broad Institute, Inc. and the Massachusetts Institute of Technology (MIT). These esteemed organizations have provided a fertile ground for Makarova to pursue their groundbreaking research and contribute to the advancement of CRISPR technologies.

Collaborations:

Makarova has had the privilege of collaborating with several notable researchers and scientists. Two prominent figures in their esteemed network are Feng Zhang and Yuri I. Wolf. These collaborations not only enrich the collective knowledge but also foster an environment conducive to innovation and transformative breakthroughs.

Conclusion:

Kira S. Makarova's journey as an inventor and innovator in the realm of CRISPR technologies has undoubtedly left an indelible mark on the field of nucleic acid targeting. With four patents to their name and a reputation built on pioneering research, Makarova continues to shape the future of genetic engineering and therapeutic interventions. Keep an eye on this brilliant mind as they pave the way for new possibilities in the world of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…